Rewolinski Melissa
- SEC CIK
- 0001780206
No open-market purchases or sales filed in the past year.
Current role at each company
- ABUS Arbutus Biopharma CorpDirectoras of May 24, 2024
- LCI Lannett Co IncDirectoras of Sep 15, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rewolinski Melissa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LCI Lannett Co Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 (view filing)4:52 PM ET | Sep 14 | 1 day | Rewolinski MelissaDirector | PPurchase | +31.2K | $0.49 | +$15.3K | +50.2%93.3K after | |
| Sep 13, 2021 (view filing) | Sep 9 | 4 days | Rewolinski MelissaDirector | SSale | −25.3K | $3.18 | −$80.6K | −29.0%62.1K after |